| Literature DB >> 33673409 |
Chiara Mazziotta1, Carmen Lanzillotti1, Maria Rosa Iaquinta1, Francesca Taraballi2,3, Elena Torreggiani1, John Charles Rotondo1, Lucia Otòn-Gonzalez1, Elisa Mazzoni1, Francesca Frontini1, Ilaria Bononi1, Monica De Mattei1, Mauro Tognon1, Fernanda Martini1,4.
Abstract
Mesenchymal stem cells (MSCs) have been identified in many adult tissues and they have been closely studied in recent years, especially in view of their potential use for treating diseases and damaged tissues and organs. MSCs are capable of self-replication and differentiation into osteoblasts and are considered an important source of cells in tissue engineering for bone regeneration. Several epigenetic factors are believed to play a role in the osteogenic differentiation of MSCs, including microRNAs (miRNAs). MiRNAs are small, single-stranded, non-coding RNAs of approximately 22 nucleotides that are able to regulate cell proliferation, differentiation and apoptosis by binding the 3' untranslated region (3'-UTR) of target mRNAs, which can be subsequently degraded or translationally silenced. MiRNAs control gene expression in osteogenic differentiation by regulating two crucial signaling cascades in osteogenesis: the transforming growth factor-beta (TGF-β)/bone morphogenic protein (BMP) and the Wingless/Int-1(Wnt)/β-catenin signaling pathways. This review provides an overview of the miRNAs involved in osteogenic differentiation and how these miRNAs could regulate the expression of target genes.Entities:
Keywords: MSCs; bone; bone regeneration; cell differentiation; mesenchymal stem cells; miRNA; miRNAome; microRNA; osteogenesis; osteogenic differentiation; stem cells
Mesh:
Substances:
Year: 2021 PMID: 33673409 PMCID: PMC7956574 DOI: 10.3390/ijms22052362
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208